Prognostic Utility of ApoB/AI, Total Cholesterol/Hdl, Non-HDL Cholesterol, or Hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes: Results From PROVE IT-TIMI 22

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.108.181735
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Beyond LDL-Cholesterol: The Role of Low HDL-Cholesterol and Elevated TG in Residual Cardiovascular Risk Remaining After Statin Therapy

Journal of Managed Care Pharmacy
2008English

HDL Cholesterol and Coronary Artery Occlusion.

BMJ
1978English

Non-HDL Cholesterol: Into the Spotlight

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

ApoCIII Enrichment in HDL Impairs HDL-mediated Cholesterol Efflux Capacity

Scientific Reports
Multidisciplinary
2017English

Cholesterol Efflux as a Measure of HDL Functionality in Humans

English

Origins of Intestinal ABCA1-mediated HDL-cholesterol

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2008English

HDL-Cholesterol Levels Among Rural Inhabitants

JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE
1981English

Triglycerides and HDL Cholesterol: Stars or Second Leads in Diabetes?

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2009English

Prognostic Significance of Hs-CRP in Acute Ischemic Stroke Patients

International Journal of Advances in Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy